HOLX (STOCKS)
Hologic Inc
$75.090000
-0.060000 (-0.08%)
Prev close: $75.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stephen P. MacMillan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16,841.89M
- Employees
- 7,063
- P/E (TTM)
- 31.16
- P/B (TTM)
- 3.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
20
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q1)
|
$1.04 | $1.11 | -0.0718 | -6.45% |
|
Sep 2025 (Q4)
|
$1.13 | $1.12 | +0.0076 | +0.68% |
|
Jun 2025 (Q3)
|
$1.08 | $1.07 | +0.0081 | +0.76% |
|
Mar 2025 (Q2)
|
$1.03 | $1.04 | -0.0065 | -0.63% |
Financial Statements
| Revenues | $4.13B |
| Benefits Costs and Expenses | $3.46B |
| Cost Of Revenue | $1.58B |
| Costs And Expenses | $3.46B |
| Gross Profit | $2.12B |
| Operating Expenses | $1.40B |
| Research and Development | $248.50M |
| Other Operating Expenses | $1.15B |
| Operating Income/Loss | $721.50M |
| Income/Loss From Continuing Operations After Tax | $543.80M |
| Income/Loss From Continuing Operations Before Tax | $623.40M |
| Income Tax Expense/Benefit | $119.60M |
| Income Tax Expense/Benefit, Deferred | -$123.20M |
| Net Income/Loss | $543.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $543.80M |
| Net Income/Loss Available To Common Stockholders, Basic | $543.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.42 |
| Diluted Earnings Per Share | $2.40 |
| Basic Average Shares | 673,859,000 |
| Diluted Average Shares | 676,502,000 |
| Assets | $9.18B |
| Current Assets | $3.84B |
| Cash | $2.36B |
| Inventory | $688.50M |
| Other Current Assets | $790.30M |
| Noncurrent Assets | $5.34B |
| Fixed Assets | $568.30M |
| Intangible Assets | $547.30M |
| Other Non-current Assets | $4.22B |
| Liabilities | $3.94B |
| Current Liabilities | $951.30M |
| Accounts Payable | $201.10M |
| Other Current Liabilities | $750.20M |
| Noncurrent Liabilities | $2.98B |
| Long-term Debt | $2.51B |
| Other Non-current Liabilities | $475.60M |
| Equity | $5.25B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.25B |
| Liabilities And Equity | $9.18B |
| Net Cash Flow From Operating Activities | $1.10B |
| Net Cash Flow From Operating Activities, Continuing | $1.10B |
| Net Cash Flow From Investing Activities | -$472.80M |
| Net Cash Flow From Investing Activities, Continuing | -$472.80M |
| Net Cash Flow From Financing Activities | -$250.90M |
| Net Cash Flow From Financing Activities, Continuing | -$250.90M |
| Exchange Gains/Losses | $11.90M |
| Net Cash Flow | $385.90M |
| Net Cash Flow, Continuing | $374.00M |
| Comprehensive Income/Loss | $549.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $622.40M |
| Other Comprehensive Income/Loss | $185.10M |